Some medical devices could get faster approval with new FDA rules

By Gayle S. Putrich
Staff Reporter

Published: April 22, 2014 7:41 pm ET
Updated: April 22, 2014 7:46 pm ET

Related to this story

Topics Medical Public Policy United States
Companies & Associations

WASHINGTON — The U.S. Food and Drug Administration is proposing an expedited approval for medical devices for devices aimed at the diagnosis or treatment of patients with serious conditions that would otherwise go untreated.

Introduced April 22, the “Expedited Access Premarket Approval Application for Unmet Medical Needs for Life Threatening or Irreversibly Debilitating Diseases or Conditions,” or “Expedited Access PMA” would include earlier and more engaged interaction with senior-level FDA staff which the agency believes will lead to faster patient access to safe medical devices. 

“We are excited to offer a proposed program for expedited access for certain high-risk medical devices,” said Dr. Jeffrey Shuren, director of the FDA’s Center for Devices and Radiological Health. “The program allows manufacturers to engage early and often with the agency. We expect most devices that enter this program will be in the pre-clinical trial phase.” 

The program builds on the FDA’s experience with expedited review programs for pharmaceuticals and would be open to devices that are intended to treat or diagnose a life-threatening or irreversibly-debilitating disease or condition for which no approved alternative treatment or diagnostic equipment exists, or for a breakthrough technology that provides a clinical advantage over existing technology or approved alternatives. Participating device manufacturers must have an acceptable data development plan that has been approved by the FDA.

According to the agency, the Expedited Access PMA is not a new pathway to market, but a collaborative approach to facilitate product development under existing regulations. While other existing device programs have focused on reducing the time for pre-market review, the new approach, if adopted, would aim to also reduce the time associated with product development.

In a separate draft guidance, the also outlined the agency’s current policy on when data can be collected after product approval and what actions are available to the FDA if approval conditions, such as post-market data collection, are not met.

Included in the guidance is advice on the use of surrogate or independent markers to support approval, similar to the data points used for accelerated approval of prescription drugs.

Both proposals are open for public comment at www.fda.gov/medicaldevices


Comments

Some medical devices could get faster approval with new FDA rules

By Gayle S. Putrich
Staff Reporter

Published: April 22, 2014 7:41 pm ET
Updated: April 22, 2014 7:46 pm ET

Post Your Comments


Back to story


More stories

Image

Eastman Chemical expanding Tritan co-polyester capacity

March 27, 2015 10:00 am ET

Eastman Chemical Co.'s Tritan-brand co-polyester business continues to grow, with 35 million pounds of capacity added late last year and a second...    More

Image

Getting a real feel for how 'vinyl saves lives'

March 27, 2015 6:00 am ET

While I'm certainly not shipping off to Africa anytime soon, I got a taste of what medical professionals go through in the fight against Ebola and...    More

Image

Flextronics launches global injection molding, tooling unit

March 26, 2015 4:29 pm ET

Flextronics International Ltd. (Booth S34125) is officially launching Precision Plastics, a global injection tooling and manufacturing unit, as a...    More

Image

Intertech Medical adding presses, people

March 23, 2015 3:28 pm ET

Colorado's Intertech Medical has added five new injection molding presses and expects to add up to another four machines to keep up with a growth in...    More

Image

Kumar left Wall Street to run thermoforming companies

March 18, 2015 6:00 am ET

Jay Kumar was working on Wall Street before he decided to invest in manufacturing, buying Universal Plastics Co. in 2012.    More

Market Reports

Flexible Packaging Trends in North America

North America represents about 30 percent of the global consumption of flexible packaging. Annual growth in this region is forecast at 4 percent during the next 5 years.

For more insight on growth opportunities, drivers of growth and the outlook for 2015, download this report.

Learn more

Plastics Recycling Trends in North America

This report is a review and analysis of the North American Plastics Recycling Industry, including key trends and statistics based on 2013 performance. We examine market environment factors, regulatory issues, industry challenges, key drivers and emerging trends in post-consumer and post-industrial recycling.

Learn more

Plastics in Mexico - State of the Industry Report

This report analyzes the $20 billion plastics industry in Mexico including sales of machinery & equipment, resins and finished products.

Our analysts provide insight on business trends, foreign investment, top end markets and plastics processing activity. The report also provides important data on exports, production, employment and value of plastics products manufactured.

Learn more

Upcoming Plastics News Events

June 2, 2015 - June 3, 2015Plastics Financial Summit - Chicago 2015

September 16, 2015 - September 18, 2015Plastics Caps & Closures - September 2015

More Events